Effect of Baseline Resistance-Associated Substitutions on Thalassemia Patients with Chronic HCV Infection: A Two-Year Follow-Up

BACKGROUND Direct-acting antivirals (DAAs) against hepatitis C virus (HCV) infection showed the presence of resistant-associated substitutions (RASs). The aim of the present study was to carry out a follow-up of patients with baseline RASs to report the impact of RASs on DAA therapy outcome. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Safarnezhad Tameshkel, Fahimeh, Karbalaie Niya, Mohammad Hadi, Khoonsari, Mahmoodreza, Ajdarkosh, Hossein, Faraji, Amir Hossein, Nikkhah, Mehdi, Motamed, Nima, Azarkeivan, Azita, Gholami, Ali, Sohrabi, Masood Reza, Keyvani, Hossein, Zamani, Farhad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Association of Gastroerterology and Hepatology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531936/
https://www.ncbi.nlm.nih.gov/pubmed/34712435
http://dx.doi.org/10.34172/mejdd.2021.200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531936/
https://www.ncbi.nlm.nih.gov/pubmed/34712435
http://dx.doi.org/10.34172/mejdd.2021.200

Ejemplares similares